Fennec Pharmaceuticals Inc (FENC) — Capital Reinvestment Ratio

Latest as of March 2026: 0.00x

Fennec Pharmaceuticals Inc (FENC) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($2.38 Million) in capital expenditures ($1.00). See FENC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$2.38 Million

USD

Capital Expenditures

$1.00

USD

Data as of

Mar 2026

Most recent filing

Annual Capital Reinvestment Ratio for Fennec Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Fennec Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see Fennec Pharmaceuticals Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow